Summary

The global Digital Health For Obesity market is projected to grow from US$ 935 million in 2025 to US$ 1706 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications. Digital Health For Obesity refers to digital healthcare solutions designed to support obesity prevention, weight management, obesity treatment assistance, and metabolic health improvement through digital technologies. The solutions integrate mobile applications, artificial intelligence, telehealth services, wearable devices, health data platforms, and digital therapeutics to provide personalized lifestyle intervention, nutrition guidance, physical activity management, health monitoring, and clinical support. Digital Health For Obesity utilizes individual health information, behavioral data, biometric indicators, and continuous monitoring capabilities to deliver personalized obesity management programs for individuals, healthcare providers, employers, and preventive healthcare organizations. Key Findings Digital Health For Obesity combines digital therapeutics, telehealth, AI analytics, and personalized health management capabilities Weight management and metabolic health management represent major application areas within Digital Health For Obesity North America remains a leading commercial region due to advanced digital healthcare adoption and obesity management demand Asia Pacific is becoming an important emerging market supported by expanding digital health infrastructure Personalized intervention based on health data integration is a key development direction of Digital Health For Obesity Market Trends Digital Health For Obesity is evolving from basic weight tracking applications toward integrated digital health ecosystems combining behavioral coaching, artificial intelligence, remote healthcare services, and personalized treatment support. The increasing focus on obesity as a chronic disease is accelerating demand for continuous monitoring, individualized intervention programs, and technology-enabled healthcare management. Future development is expected to emphasize integration of wearable devices, metabolic indicators, lifestyle data, and clinical treatment pathways to improve long-term weight management outcomes and patient engagement. Market Dynamics Drivers Rising global obesity prevalence and increasing recognition of obesity as a chronic metabolic disease are major drivers for Digital Health For Obesity adoption. Healthcare systems, employers, and individuals are increasingly seeking scalable digital solutions to support weight reduction, lifestyle modification, and preventive health management. Advances in artificial intelligence, remote monitoring technologies, and connected health devices are further improving the ability to provide personalized and continuous obesity management services. Restraints Digital Health For Obesity faces challenges related to patient adherence, data privacy requirements, regulatory uncertainty, and differences in healthcare reimbursement models across regions. Maintaining long-term user engagement remains difficult for digital weight management solutions, while clinical validation requirements and integration with existing healthcare systems increase operational complexity. Opportunities Growing demand for personalized medicine, metabolic health management, and preventive healthcare creates significant opportunities for Digital Health For Obesity. Integration with wearable devices, continuous glucose monitoring, AI-based recommendations, and healthcare provider networks provides opportunities to develop more comprehensive obesity management platforms. Expanding employer wellness programs and digital healthcare adoption in emerging markets also provide additional growth opportunities. Challenges The market faces challenges from increasing competition, differentiation difficulties among digital health platforms, and the need to demonstrate measurable clinical outcomes. Providers must continuously improve algorithm accuracy, user experience, medical credibility, and healthcare integration capabilities while adapting to evolving regulatory requirements. Value Chain Analysis The value chain of Digital Health For Obesity includes upstream technology providers, healthcare data suppliers, wearable device manufacturers, digital therapeutics developers, and artificial intelligence technology providers. The middle segment consists of digital health platform operators that integrate health data collection, analytics, coaching services, remote consultations, and personalized intervention programs. Value creation depends on combining digital technology with healthcare expertise to improve obesity management efficiency and patient outcomes. The downstream ecosystem includes individuals seeking weight management support, healthcare institutions providing obesity treatment services, employers implementing wellness programs, and preventive healthcare organizations. As obesity management becomes increasingly personalized, digital platforms are expected to play a greater role in connecting lifestyle management, clinical care, and continuous health monitoring. Segment Insights By technology type, Mobile Application-Based Solution, AI and Machine Learning-Based Solution, Telehealth-Based Solution, Wearable Device-Integrated Solution, and Digital Therapeutics-Based Solution represent the major segments of Digital Health For Obesity. Mobile applications and telehealth solutions currently represent widely adopted approaches due to accessibility and scalability, while AI-driven solutions and wearable-integrated platforms are gaining importance through improved personalization and continuous health data analysis. By application, Weight Management and Metabolic Health Management represent core demand areas, followed by Obesity Treatment Support, Employer Wellness Program, and Preventive Healthcare. Solutions targeting metabolic indicators, behavioral modification, and long-term lifestyle management are expected to maintain strong relevance as healthcare systems shift from treatment-oriented models toward prevention and chronic disease management. Downstream Market Opportunities The primary downstream opportunities for Digital Health For Obesity are individuals requiring weight management support, healthcare providers treating obesity-related conditions, and organizations implementing preventive health programs. Pharmaceutical companies and healthcare providers are also increasingly exploring digital solutions to complement obesity treatment pathways, particularly through continuous monitoring, behavioral intervention, and patient engagement programs. Employer-sponsored wellness initiatives represent another important application area as organizations seek scalable approaches to improve employee health outcomes. Regional Insights North America represents a leading regional market for Digital Health For Obesity due to strong digital healthcare adoption, advanced telehealth infrastructure, high obesity management demand, and established healthcare technology ecosystems. The region has developed a mature environment for digital weight management platforms, remote care models, and technology-assisted chronic disease management. Asia Pacific is emerging as a high-potential region driven by expanding healthcare digitalization, increasing awareness of obesity management, and growing investment in health technology platforms. Japan, China, South Korea, and other regional markets are strengthening digital healthcare capabilities, creating opportunities for localized obesity management solutions. Europe also maintains significant potential supported by healthcare innovation, preventive health initiatives, and increasing adoption of digital healthcare services. Competitive Landscape Analysis The competitive landscape of Digital Health For Obesity includes digital health companies, telehealth providers, healthcare technology companies, medical device companies, and integrated healthcare platforms. Competition is primarily based on personalization capability, clinical effectiveness, technology integration, user engagement, healthcare partnerships, and scalability of service delivery. Leading participants are increasingly developing comprehensive solutions that combine digital coaching, AI analytics, wearable data integration, and healthcare support services to address the complex and long-term nature of obesity management. Report Scope This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Digital Health For Obesity market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers. By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern. Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends. Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths. A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand. Market Segmentation By Company Omada Health, Inc. Noom Inc. Teladoc Health, Inc. Hims & Hers Health, Inc. Vida Health, Inc. WW International, Inc. Lark Health Corp. DarioHealth Corp. Twin Health Inc. Virta Health Corp. Oviva AG mySugr GmbH (Roche) Ada Health GmbH Medtronic plc Fitterfly Healthtech Pvt. Ltd. HealthifyMe Wellness Pvt. Ltd. Welldoc, Inc. Ypsomed AG Ping An Healthcare and Technology Company Limited JD Health International Inc. iCarbonX Oishi Kenko Inc. JMDC Inc. Segment by Type Mobile Application-Based Solution AI and Machine Learning-Based Solution Telehealth-Based Solution Wearable Device-Integrated Solution Digital Therapeutics-Based Solution Segment by Health Management Function Weight Tracking and Behavior Management Nutrition Management and Diet Coaching Physical Activity Management Metabolic Health Monitoring Medication Support and Obesity Treatment Management Segment by Body Mass Index Underweight Management (<18.5 BMI) Healthy Weight Management (18.5–24.9 BMI) Overweight Management (25.0–29.9 BMI) Class I Obesity Management (30.0–34.9 BMI) Class II Obesity Management (35.0–39.9 BMI) Class III Obesity Management (≥40.0 BMI) Segment by Application Weight Management Obesity Treatment Support Metabolic Health Management Employer Wellness Program Preventive Healthcare Others Segment by Region North America United States Canada Mexico Asia-Pacific China Japan South Korea India Australia Vietnam Indonesia Malaysia Philippines Singapore Rest of Asia Europe Germany U.K. France Italy Spain Benelux Russia Rest of Europe Central and South America Brazil Argentina Rest of Central and South America Middle East & Africa GCC Countries Egypt Israel South Africa Rest of MEA Chapter Outline Chapter 1: Defines the Digital Health For Obesity study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies Chapter 14: Actionable conclusions and strategic recommendations. Why This Report Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to: Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5). Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence. Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11). Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14). Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Digital Health For Obesity: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Digital Health For Obesity Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Mobile Application-Based Solution
1.2.3 AI and Machine Learning-Based Solution
1.2.4 Telehealth-Based Solution
1.2.5 Wearable Device-Integrated Solution
1.2.6 Digital Therapeutics-Based Solution
1.3 Market Segmentation by Health Management Function
1.3.1 Global Digital Health For Obesity Market Size by Health Management Function, 2021 vs 2025 vs 2032
1.3.2 Weight Tracking and Behavior Management
1.3.3 Nutrition Management and Diet Coaching
1.3.4 Physical Activity Management
1.3.5 Metabolic Health Monitoring
1.3.6 Medication Support and Obesity Treatment Management
1.4 Market Segmentation by Body Mass Index
1.4.1 Global Digital Health For Obesity Market Size by Body Mass Index, 2021 vs 2025 vs 2032
1.4.2 Underweight Management (<18.5 BMI)
1.4.3 Healthy Weight Management (18.5–24.9 BMI)
1.4.4 Overweight Management (25.0–29.9 BMI)
1.4.5 Class I Obesity Management (30.0–34.9 BMI)
1.4.6 Class II Obesity Management (35.0–39.9 BMI)
1.4.7 Class III Obesity Management (≥40.0 BMI)
1.5 Market Segmentation by Application
1.5.1 Global Digital Health For Obesity Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Weight Management
1.5.3 Obesity Treatment Support
1.5.4 Metabolic Health Management
1.5.5 Employer Wellness Program
1.5.6 Preventive Healthcare
1.5.7 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Digital Health For Obesity Revenue Estimates and Forecasts (2021-2032)
2.2 Global Digital Health For Obesity Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape
3.1 Global Digital Health For Obesity Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Digital Health For Obesity Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Mobile Application-Based Solution: Market Share by Key Players
3.3.2 AI and Machine Learning-Based Solution: Market Share by Key Players
3.3.3 Telehealth-Based Solution: Market Share by Key Players
3.3.4 Wearable Device-Integrated Solution: Market Share by Key Players
3.3.5 Digital Therapeutics-Based Solution: Market Share by Key Players
3.4 Global Digital Health For Obesity Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation
4.1 Global Digital Health For Obesity Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Digital Health For Obesity Market by Health Management Function
4.2.1 Global Revenue by Health Management Function (2021-2032)
4.2.2 Global Revenue-Based Market Share by Health Management Function (2021-2032)
4.3 Global Digital Health For Obesity Market by Body Mass Index
4.3.1 Global Revenue by Body Mass Index (2021-2032)
4.3.2 Global Revenue-Based Market Share by Body Mass Index (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Digital Health For Obesity Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application

6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Digital Health For Obesity Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Digital Health For Obesity Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico

7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Digital Health For Obesity Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Digital Health For Obesity Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia

8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Digital Health For Obesity Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Digital Health For Obesity Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore

9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Digital Health For Obesity Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Digital Health For Obesity Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Digital Health For Obesity Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Digital Health For Obesity Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Omada Health, Inc.
11.1.1 Omada Health, Inc. Corporation Information
11.1.2 Omada Health, Inc. Business Overview
11.1.3 Omada Health, Inc. Digital Health For Obesity Product Features and Attributes
11.1.4 Omada Health, Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.1.5 Omada Health, Inc. Digital Health For Obesity Revenue by Product in 2025
11.1.6 Omada Health, Inc. Digital Health For Obesity Revenue by Application in 2025
11.1.7 Omada Health, Inc. Digital Health For Obesity Revenue by Geographic Area in 2025
11.1.8 Omada Health, Inc. Digital Health For Obesity SWOT Analysis
11.1.9 Omada Health, Inc. Recent Developments
11.2 Noom Inc.
11.2.1 Noom Inc. Corporation Information
11.2.2 Noom Inc. Business Overview
11.2.3 Noom Inc. Digital Health For Obesity Product Features and Attributes
11.2.4 Noom Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.2.5 Noom Inc. Digital Health For Obesity Revenue by Product in 2025
11.2.6 Noom Inc. Digital Health For Obesity Revenue by Application in 2025
11.2.7 Noom Inc. Digital Health For Obesity Revenue by Geographic Area in 2025
11.2.8 Noom Inc. Digital Health For Obesity SWOT Analysis
11.2.9 Noom Inc. Recent Developments
11.3 Teladoc Health, Inc.
11.3.1 Teladoc Health, Inc. Corporation Information
11.3.2 Teladoc Health, Inc. Business Overview
11.3.3 Teladoc Health, Inc. Digital Health For Obesity Product Features and Attributes
11.3.4 Teladoc Health, Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.3.5 Teladoc Health, Inc. Digital Health For Obesity Revenue by Product in 2025
11.3.6 Teladoc Health, Inc. Digital Health For Obesity Revenue by Application in 2025
11.3.7 Teladoc Health, Inc. Digital Health For Obesity Revenue by Geographic Area in 2025
11.3.8 Teladoc Health, Inc. Digital Health For Obesity SWOT Analysis
11.3.9 Teladoc Health, Inc. Recent Developments
11.4 Hims & Hers Health, Inc.
11.4.1 Hims & Hers Health, Inc. Corporation Information
11.4.2 Hims & Hers Health, Inc. Business Overview
11.4.3 Hims & Hers Health, Inc. Digital Health For Obesity Product Features and Attributes
11.4.4 Hims & Hers Health, Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.4.5 Hims & Hers Health, Inc. Digital Health For Obesity Revenue by Product in 2025
11.4.6 Hims & Hers Health, Inc. Digital Health For Obesity Revenue by Application in 2025
11.4.7 Hims & Hers Health, Inc. Digital Health For Obesity Revenue by Geographic Area in 2025
11.4.8 Hims & Hers Health, Inc. Digital Health For Obesity SWOT Analysis
11.4.9 Hims & Hers Health, Inc. Recent Developments
11.5 Vida Health, Inc.
11.5.1 Vida Health, Inc. Corporation Information
11.5.2 Vida Health, Inc. Business Overview
11.5.3 Vida Health, Inc. Digital Health For Obesity Product Features and Attributes
11.5.4 Vida Health, Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.5.5 Vida Health, Inc. Digital Health For Obesity Revenue by Product in 2025
11.5.6 Vida Health, Inc. Digital Health For Obesity Revenue by Application in 2025
11.5.7 Vida Health, Inc. Digital Health For Obesity Revenue by Geographic Area in 2025
11.5.8 Vida Health, Inc. Digital Health For Obesity SWOT Analysis
11.5.9 Vida Health, Inc. Recent Developments
11.6 WW International, Inc.
11.6.1 WW International, Inc. Corporation Information
11.6.2 WW International, Inc. Business Overview
11.6.3 WW International, Inc. Digital Health For Obesity Product Features and Attributes
11.6.4 WW International, Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.6.5 WW International, Inc. Recent Developments
11.7 Lark Health Corp.
11.7.1 Lark Health Corp. Corporation Information
11.7.2 Lark Health Corp. Business Overview
11.7.3 Lark Health Corp. Digital Health For Obesity Product Features and Attributes
11.7.4 Lark Health Corp. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.7.5 Lark Health Corp. Recent Developments
11.8 DarioHealth Corp.
11.8.1 DarioHealth Corp. Corporation Information
11.8.2 DarioHealth Corp. Business Overview
11.8.3 DarioHealth Corp. Digital Health For Obesity Product Features and Attributes
11.8.4 DarioHealth Corp. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.8.5 DarioHealth Corp. Recent Developments
11.9 Twin Health Inc.
11.9.1 Twin Health Inc. Corporation Information
11.9.2 Twin Health Inc. Business Overview
11.9.3 Twin Health Inc. Digital Health For Obesity Product Features and Attributes
11.9.4 Twin Health Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.9.5 Twin Health Inc. Recent Developments
11.10 Virta Health Corp.
11.10.1 Virta Health Corp. Corporation Information
11.10.2 Virta Health Corp. Business Overview
11.10.3 Virta Health Corp. Digital Health For Obesity Product Features and Attributes
11.10.4 Virta Health Corp. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Oviva AG
11.11.1 Oviva AG Corporation Information
11.11.2 Oviva AG Business Overview
11.11.3 Oviva AG Digital Health For Obesity Product Features and Attributes
11.11.4 Oviva AG Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.11.5 Oviva AG Recent Developments
11.12 mySugr GmbH (Roche)
11.12.1 mySugr GmbH (Roche) Corporation Information
11.12.2 mySugr GmbH (Roche) Business Overview
11.12.3 mySugr GmbH (Roche) Digital Health For Obesity Product Features and Attributes
11.12.4 mySugr GmbH (Roche) Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.12.5 mySugr GmbH (Roche) Recent Developments
11.13 Ada Health GmbH
11.13.1 Ada Health GmbH Corporation Information
11.13.2 Ada Health GmbH Business Overview
11.13.3 Ada Health GmbH Digital Health For Obesity Product Features and Attributes
11.13.4 Ada Health GmbH Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.13.5 Ada Health GmbH Recent Developments
11.14 Medtronic plc
11.14.1 Medtronic plc Corporation Information
11.14.2 Medtronic plc Business Overview
11.14.3 Medtronic plc Digital Health For Obesity Product Features and Attributes
11.14.4 Medtronic plc Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.14.5 Medtronic plc Recent Developments
11.15 Fitterfly Healthtech Pvt. Ltd.
11.15.1 Fitterfly Healthtech Pvt. Ltd. Corporation Information
11.15.2 Fitterfly Healthtech Pvt. Ltd. Business Overview
11.15.3 Fitterfly Healthtech Pvt. Ltd. Digital Health For Obesity Product Features and Attributes
11.15.4 Fitterfly Healthtech Pvt. Ltd. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.15.5 Fitterfly Healthtech Pvt. Ltd. Recent Developments
11.16 HealthifyMe Wellness Pvt. Ltd.
11.16.1 HealthifyMe Wellness Pvt. Ltd. Corporation Information
11.16.2 HealthifyMe Wellness Pvt. Ltd. Business Overview
11.16.3 HealthifyMe Wellness Pvt. Ltd. Digital Health For Obesity Product Features and Attributes
11.16.4 HealthifyMe Wellness Pvt. Ltd. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.16.5 HealthifyMe Wellness Pvt. Ltd. Recent Developments
11.17 Welldoc, Inc.
11.17.1 Welldoc, Inc. Corporation Information
11.17.2 Welldoc, Inc. Business Overview
11.17.3 Welldoc, Inc. Digital Health For Obesity Product Features and Attributes
11.17.4 Welldoc, Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.17.5 Welldoc, Inc. Recent Developments
11.18 Ypsomed AG
11.18.1 Ypsomed AG Corporation Information
11.18.2 Ypsomed AG Business Overview
11.18.3 Ypsomed AG Digital Health For Obesity Product Features and Attributes
11.18.4 Ypsomed AG Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.18.5 Ypsomed AG Recent Developments
11.19 Ping An Healthcare and Technology Company Limited
11.19.1 Ping An Healthcare and Technology Company Limited Corporation Information
11.19.2 Ping An Healthcare and Technology Company Limited Business Overview
11.19.3 Ping An Healthcare and Technology Company Limited Digital Health For Obesity Product Features and Attributes
11.19.4 Ping An Healthcare and Technology Company Limited Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.19.5 Ping An Healthcare and Technology Company Limited Recent Developments
11.20 JD Health International Inc.
11.20.1 JD Health International Inc. Corporation Information
11.20.2 JD Health International Inc. Business Overview
11.20.3 JD Health International Inc. Digital Health For Obesity Product Features and Attributes
11.20.4 JD Health International Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.20.5 JD Health International Inc. Recent Developments
11.21 iCarbonX
11.21.1 iCarbonX Corporation Information
11.21.2 iCarbonX Business Overview
11.21.3 iCarbonX Digital Health For Obesity Product Features and Attributes
11.21.4 iCarbonX Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.21.5 iCarbonX Recent Developments
11.22 Oishi Kenko Inc.
11.22.1 Oishi Kenko Inc. Corporation Information
11.22.2 Oishi Kenko Inc. Business Overview
11.22.3 Oishi Kenko Inc. Digital Health For Obesity Product Features and Attributes
11.22.4 Oishi Kenko Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.22.5 Oishi Kenko Inc. Recent Developments
11.23 JMDC Inc.
11.23.1 JMDC Inc. Corporation Information
11.23.2 JMDC Inc. Business Overview
11.23.3 JMDC Inc. Digital Health For Obesity Product Features and Attributes
11.23.4 JMDC Inc. Digital Health For Obesity Revenue and Gross Margin (2021-2026)
11.23.5 JMDC Inc. Recent Developments

12 Digital Health For Obesity Value Chain and Ecosystem Analysis
12.1 Digital Health For Obesity Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Digital Health For Obesity Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Digital Health For Obesity Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Digital Health For Obesity Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Digital Health For Obesity Market Size Growth Rate by Health Management Function, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Digital Health For Obesity Market Size Growth Rate by Body Mass Index, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Digital Health For Obesity Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Digital Health For Obesity Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Digital Health For Obesity Revenue by Region (US$ Million), 2021-2026
Table 7. Global Digital Health For Obesity Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Digital Health For Obesity Revenue by Players (US$ Million), 2021-2026
Table 10. Global Digital Health For Obesity Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Digital Health For Obesity Revenue, 2025
Table 13. Global Digital Health For Obesity Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Digital Health For Obesity Companies Headquarters
Table 15. Global Digital Health For Obesity Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Digital Health For Obesity Revenue by Type (US$ Million), 2021-2026
Table 19. Global Digital Health For Obesity Revenue by Type (US$ Million), 2027-2032
Table 20. Global Digital Health For Obesity Revenue by Health Management Function (US$ Million), 2021-2026
Table 21. Global Digital Health For Obesity Revenue by Health Management Function (US$ Million), 2027-2032
Table 22. Global Digital Health For Obesity Revenue by Body Mass Index (US$ Million), 2021-2026
Table 23. Global Digital Health For Obesity Revenue by Body Mass Index (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Digital Health For Obesity Revenue by Application (US$ Million), 2021-2026
Table 26. Global Digital Health For Obesity Revenue by Application (US$ Million), 2027-2032
Table 27. Digital Health For Obesity High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Digital Health For Obesity Growth Accelerators and Market Barriers
Table 31. North America Digital Health For Obesity Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Digital Health For Obesity Growth Accelerators and Market Barriers
Table 33. Europe Digital Health For Obesity Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Digital Health For Obesity Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Digital Health For Obesity Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Digital Health For Obesity Investment Opportunities and Key Challenges
Table 37. Central and South America Digital Health For Obesity Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Digital Health For Obesity Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Digital Health For Obesity Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. Omada Health, Inc. Corporation Information
Table 41. Omada Health, Inc. Description and Major Businesses
Table 42. Omada Health, Inc. Product Features and Attributes
Table 43. Omada Health, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Omada Health, Inc. Revenue Proportion by Product in 2025
Table 45. Omada Health, Inc. Revenue Proportion by Application in 2025
Table 46. Omada Health, Inc. Revenue Proportion by Geographic Area in 2025
Table 47. Omada Health, Inc. Digital Health For Obesity SWOT Analysis
Table 48. Omada Health, Inc. Recent Developments
Table 49. Noom Inc. Corporation Information
Table 50. Noom Inc. Description and Major Businesses
Table 51. Noom Inc. Product Features and Attributes
Table 52. Noom Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Noom Inc. Revenue Proportion by Product in 2025
Table 54. Noom Inc. Revenue Proportion by Application in 2025
Table 55. Noom Inc. Revenue Proportion by Geographic Area in 2025
Table 56. Noom Inc. Digital Health For Obesity SWOT Analysis
Table 57. Noom Inc. Recent Developments
Table 58. Teladoc Health, Inc. Corporation Information
Table 59. Teladoc Health, Inc. Description and Major Businesses
Table 60. Teladoc Health, Inc. Product Features and Attributes
Table 61. Teladoc Health, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Teladoc Health, Inc. Revenue Proportion by Product in 2025
Table 63. Teladoc Health, Inc. Revenue Proportion by Application in 2025
Table 64. Teladoc Health, Inc. Revenue Proportion by Geographic Area in 2025
Table 65. Teladoc Health, Inc. Digital Health For Obesity SWOT Analysis
Table 66. Teladoc Health, Inc. Recent Developments
Table 67. Hims & Hers Health, Inc. Corporation Information
Table 68. Hims & Hers Health, Inc. Description and Major Businesses
Table 69. Hims & Hers Health, Inc. Product Features and Attributes
Table 70. Hims & Hers Health, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Hims & Hers Health, Inc. Revenue Proportion by Product in 2025
Table 72. Hims & Hers Health, Inc. Revenue Proportion by Application in 2025
Table 73. Hims & Hers Health, Inc. Revenue Proportion by Geographic Area in 2025
Table 74. Hims & Hers Health, Inc. Digital Health For Obesity SWOT Analysis
Table 75. Hims & Hers Health, Inc. Recent Developments
Table 76. Vida Health, Inc. Corporation Information
Table 77. Vida Health, Inc. Description and Major Businesses
Table 78. Vida Health, Inc. Product Features and Attributes
Table 79. Vida Health, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Vida Health, Inc. Revenue Proportion by Product in 2025
Table 81. Vida Health, Inc. Revenue Proportion by Application in 2025
Table 82. Vida Health, Inc. Revenue Proportion by Geographic Area in 2025
Table 83. Vida Health, Inc. Digital Health For Obesity SWOT Analysis
Table 84. Vida Health, Inc. Recent Developments
Table 85. WW International, Inc. Corporation Information
Table 86. WW International, Inc. Description and Major Businesses
Table 87. WW International, Inc. Product Features and Attributes
Table 88. WW International, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. WW International, Inc. Recent Developments
Table 90. Lark Health Corp. Corporation Information
Table 91. Lark Health Corp. Description and Major Businesses
Table 92. Lark Health Corp. Product Features and Attributes
Table 93. Lark Health Corp. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. Lark Health Corp. Recent Developments
Table 95. DarioHealth Corp. Corporation Information
Table 96. DarioHealth Corp. Description and Major Businesses
Table 97. DarioHealth Corp. Product Features and Attributes
Table 98. DarioHealth Corp. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. DarioHealth Corp. Recent Developments
Table 100. Twin Health Inc. Corporation Information
Table 101. Twin Health Inc. Description and Major Businesses
Table 102. Twin Health Inc. Product Features and Attributes
Table 103. Twin Health Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. Twin Health Inc. Recent Developments
Table 105. Virta Health Corp. Corporation Information
Table 106. Virta Health Corp. Description and Major Businesses
Table 107. Virta Health Corp. Product Features and Attributes
Table 108. Virta Health Corp. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Virta Health Corp. Recent Developments
Table 110. Oviva AG Corporation Information
Table 111. Oviva AG Description and Major Businesses
Table 112. Oviva AG Product Features and Attributes
Table 113. Oviva AG Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Oviva AG Recent Developments
Table 115. mySugr GmbH (Roche) Corporation Information
Table 116. mySugr GmbH (Roche) Description and Major Businesses
Table 117. mySugr GmbH (Roche) Product Features and Attributes
Table 118. mySugr GmbH (Roche) Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. mySugr GmbH (Roche) Recent Developments
Table 120. Ada Health GmbH Corporation Information
Table 121. Ada Health GmbH Description and Major Businesses
Table 122. Ada Health GmbH Product Features and Attributes
Table 123. Ada Health GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 124. Ada Health GmbH Recent Developments
Table 125. Medtronic plc Corporation Information
Table 126. Medtronic plc Description and Major Businesses
Table 127. Medtronic plc Product Features and Attributes
Table 128. Medtronic plc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 129. Medtronic plc Recent Developments
Table 130. Fitterfly Healthtech Pvt. Ltd. Corporation Information
Table 131. Fitterfly Healthtech Pvt. Ltd. Description and Major Businesses
Table 132. Fitterfly Healthtech Pvt. Ltd. Product Features and Attributes
Table 133. Fitterfly Healthtech Pvt. Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 134. Fitterfly Healthtech Pvt. Ltd. Recent Developments
Table 135. HealthifyMe Wellness Pvt. Ltd. Corporation Information
Table 136. HealthifyMe Wellness Pvt. Ltd. Description and Major Businesses
Table 137. HealthifyMe Wellness Pvt. Ltd. Product Features and Attributes
Table 138. HealthifyMe Wellness Pvt. Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 139. HealthifyMe Wellness Pvt. Ltd. Recent Developments
Table 140. Welldoc, Inc. Corporation Information
Table 141. Welldoc, Inc. Description and Major Businesses
Table 142. Welldoc, Inc. Product Features and Attributes
Table 143. Welldoc, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 144. Welldoc, Inc. Recent Developments
Table 145. Ypsomed AG Corporation Information
Table 146. Ypsomed AG Description and Major Businesses
Table 147. Ypsomed AG Product Features and Attributes
Table 148. Ypsomed AG Revenue (US$ Million) and Gross Margin (2021-2026)
Table 149. Ypsomed AG Recent Developments
Table 150. Ping An Healthcare and Technology Company Limited Corporation Information
Table 151. Ping An Healthcare and Technology Company Limited Description and Major Businesses
Table 152. Ping An Healthcare and Technology Company Limited Product Features and Attributes
Table 153. Ping An Healthcare and Technology Company Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 154. Ping An Healthcare and Technology Company Limited Recent Developments
Table 155. JD Health International Inc. Corporation Information
Table 156. JD Health International Inc. Description and Major Businesses
Table 157. JD Health International Inc. Product Features and Attributes
Table 158. JD Health International Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 159. JD Health International Inc. Recent Developments
Table 160. iCarbonX Corporation Information
Table 161. iCarbonX Description and Major Businesses
Table 162. iCarbonX Product Features and Attributes
Table 163. iCarbonX Revenue (US$ Million) and Gross Margin (2021-2026)
Table 164. iCarbonX Recent Developments
Table 165. Oishi Kenko Inc. Corporation Information
Table 166. Oishi Kenko Inc. Description and Major Businesses
Table 167. Oishi Kenko Inc. Product Features and Attributes
Table 168. Oishi Kenko Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 169. Oishi Kenko Inc. Recent Developments
Table 170. JMDC Inc. Corporation Information
Table 171. JMDC Inc. Description and Major Businesses
Table 172. JMDC Inc. Product Features and Attributes
Table 173. JMDC Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 174. JMDC Inc. Recent Developments
Table 175. Technologies, Platforms and Infrastructure
Table 176. Distributors List
Table 177. Market Trends and Market Evolution
Table 178. Market Drivers and Opportunities
Table 179. Market Challenges, Risks, and Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

List of Figures
Figure 1. Global Digital Health For Obesity Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Mobile Application-Based Solution Product Picture
Figure 3. AI and Machine Learning-Based Solution Product Picture
Figure 4. Telehealth-Based Solution Product Picture
Figure 5. Wearable Device-Integrated Solution Product Picture
Figure 6. Digital Therapeutics-Based Solution Product Picture
Figure 7. Global Digital Health For Obesity Market Size Growth Rate by Health Management Function, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Weight Tracking and Behavior Management Product Picture
Figure 9. Nutrition Management and Diet Coaching Product Picture
Figure 10. Physical Activity Management Product Picture
Figure 11. Metabolic Health Monitoring Product Picture
Figure 12. Medication Support and Obesity Treatment Management Product Picture
Figure 13. Global Digital Health For Obesity Market Size Growth Rate by Body Mass Index, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Underweight Management (<18.5 BMI) Product Picture
Figure 15. Healthy Weight Management (18.5–24.9 BMI) Product Picture
Figure 16. Overweight Management (25.0–29.9 BMI) Product Picture
Figure 17. Class I Obesity Management (30.0–34.9 BMI) Product Picture
Figure 18. Class II Obesity Management (35.0–39.9 BMI) Product Picture
Figure 19. Class III Obesity Management (≥40.0 BMI) Product Picture
Figure 20. Global Digital Health For Obesity Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Weight Management
Figure 22. Obesity Treatment Support
Figure 23. Metabolic Health Management
Figure 24. Employer Wellness Program
Figure 25. Preventive Healthcare
Figure 26. Others
Figure 27. Digital Health For Obesity Report Years Considered
Figure 28. Global Digital Health For Obesity Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 29. Global Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 30. Global Digital Health For Obesity Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 31. Global Digital Health For Obesity Revenue-Based Market Share by Region (2021-2032)
Figure 32. Global Digital Health For Obesity Revenue-Based Market Share Ranking (2025)
Figure 33. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 34. Mobile Application-Based Solution Revenue-Based Market Share by Player in 2025
Figure 35. AI and Machine Learning-Based Solution Revenue-Based Market Share by Player in 2025
Figure 36. Telehealth-Based Solution Revenue-Based Market Share by Player in 2025
Figure 37. Wearable Device-Integrated Solution Revenue-Based Market Share by Player in 2025
Figure 38. Digital Therapeutics-Based Solution Revenue-Based Market Share by Player in 2025
Figure 39. Global Digital Health For Obesity Revenue-Based Market Share by Type (2021-2032)
Figure 40. Global Digital Health For Obesity Revenue-Based Market Share by Health Management Function (2021-2032)
Figure 41. Global Digital Health For Obesity Revenue-Based Market Share by Body Mass Index (2021-2032)
Figure 42. Global Digital Health For Obesity Revenue-Based Market Share by Application (2021-2032)
Figure 43. North America Digital Health For Obesity Revenue YoY (US$ Million), 2021-2032
Figure 44. North America Top 5 Players Digital Health For Obesity Revenue (US$ Million) in 2025
Figure 45. North America Digital Health For Obesity Revenue (US$ Million) by Application (2021-2032)
Figure 46. US Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 47. Canada Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 48. Mexico Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 49. Europe Digital Health For Obesity Revenue YoY (US$ Million), 2021-2032
Figure 50. Europe Top 5 Players Digital Health For Obesity Revenue (US$ Million) in 2025
Figure 51. Europe Digital Health For Obesity Revenue (US$ Million) by Application (2021-2032)
Figure 52. Germany Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 53. France Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 54. U.K. Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 55. Italy Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 56. Russia Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 57. Asia-Pacific Digital Health For Obesity Revenue YoY (US$ Million), 2021-2032
Figure 58. Asia-Pacific Top 8 Players Digital Health For Obesity Revenue (US$ Million) in 2025
Figure 59. Asia-Pacific Digital Health For Obesity Revenue (US$ Million) by Application (2021-2032)
Figure 60. Indonesia Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 61. Japan Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 62. South Korea Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 63. Australia Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 64. India Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 65. Indonesia Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 66. Vietnam Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 67. Malaysia Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 68. Philippines Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 69. Singapore Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 70. Central and South America Digital Health For Obesity Revenue YoY (US$ Million), 2021-2032
Figure 71. Central and South America Top 5 Players Digital Health For Obesity Revenue (US$ Million) in 2025
Figure 72. Central and South America Digital Health For Obesity Revenue (US$ Million) by Application (2021-2032)
Figure 73. Brazil Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 74. Argentina Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 75. Middle East and Africa Digital Health For Obesity Revenue YoY (US$ Million), 2021-2032
Figure 76. Middle East and Africa Top 5 Players Digital Health For Obesity Revenue (US$ Million) in 2025
Figure 77. Middle East and Africa Digital Health For Obesity Revenue (US$ Million) by Application (2021-2032)
Figure 78. GCC Countries Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 79. Israel Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 80. Egypt Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 81. South Africa Digital Health For Obesity Revenue (US$ Million), 2021-2032
Figure 82. Digital Health For Obesity Value Chain Mapping
Figure 83. Channels of Distribution (Direct Vs Distribution)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed